Virtual Medicinal Product (VMP)
-
Tetanus immunoglobulin human 250unit solution for injection vials
Name Details
Current Name
Tetanus immunoglobulin human 250unit solution for injection vials
|
Start Date
28-06-2004
|
End Date
|
Previous Name
Tetanus immunoglobulin human 250unit injection vials
|
Start Date
30-09-2003
|
End Date
27-06-2004
|
|
Abbreviated Name
Tetanus immunoglobulin human 250unit inj vials
|
Start Date
01-05-2009
|
|
Tetanus immunoglobulin human 250unit soln for inj vials |
Previous Start Date
14-09-2004
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular
- Name Basis
- Other
Codes
- ATC Code
-
J06BB02
BNF |
Current BNF
14050200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
14050200
|
Start Date
06-11-2009
|
End Date
03-04-2022
|
Previous BNF
14050000
|
Start Date
22-02-2005
|
End Date
05-11-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
72171000001103 |
12-01-2022 |
|
333769007 |
30-09-2003 |
11-01-2022 |
VMP Ingredients
Name
Tetanus immunoglobulin human
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
250.0
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information
1 vial |
30000 |
Part VIIIA Category C |